IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Euclidean Capital LLC

Q4 2023 Holdings

Filed 2024-02-14 | 13 holdings | $888.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Spdr S&P 500 ETF TR(SPY)TR UNIT78462F103$435.9M917,14149.1%
Spdr Gold TR(GLD)GOLD SHS78463V107$265.7M1,390,00029.9%
Ishares TR(INDA)MSCI INDIA ETF46429B598$118.4M2,425,14413.3%
Rapt Therapeutics Inc(RAPTEUR)COM75382E109$16.3M657,8991.8%
Alector Inc(ALEC)COM014442107$10.4M1,307,8581.2%
Foghorn Therapeutics Inc(FHTX)COM344174107$10.2M1,573,7611.1%
23Andme Holding CoCLASS A COM90138Q108$9.4M10,243,1221.1%
Oric Pharmaceuticals Inc(ORIC)COM68622P109$9.1M989,4101.0%
PMV Pharmaceuticals Inc(PMVP)COM69353Y103$8.1M2,627,6430.9%
Tenaya Therapeutics Inc(TNYA)COM87990A106$3.3M1,015,7050.4%
NGM Biopharmaceuticals Inc(NGMUSD)COM62921N105$852.3K992,1680.1%
Surrozen Inc(SRZN)COM NEW86889P208$824.3K87,6960.1%
Surrozen Inc(SRZNW)*W EXP 08/01/20386889P117$3.3K170,8330.0%